Thomas Kumke started his career as a PhD student at the University of Technology, Braunschweig, Germany. He then moved from university research to the pharmaceutical industry, working at Hammersmith Medicines Research, London and then at UCB Pharma, first in observational studies in immunology, then in clinical development. Beginning last year, Thomas started to build up the SSI RWE Strategy Team which is responsible for the statistical strategies and conduct of real world studies at UCB. Thomas’s main interests are statistical analyses of observational studies, causal modelling, missing data analysis, multivariate statistics, pragmatic trials, and immunology.